Insight Wealth Strategies’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,867
Closed -$215K 140
2022
Q4
$215K Buy
1,867
+162
+10% +$18.9K 0.04% 132
2022
Q3
$308K Hold
1,705
0.06% 122
2022
Q2
$308K Sell
1,705
-29
-2% -$5.19K 0.06% 122
2022
Q1
$296K Buy
1,734
+96
+6% +$18.1K 0.04% 138
2021
Q4
$343K Buy
1,638
+177
+12% +$36.6K 0.05% 133
2021
Q3
$281K Buy
1,461
+66
+5% +$16.2K 0.04% 166
2021
Q2
$395K Buy
+1,395
New +$378K 0.06% 147

Other funds holding MED

Insight Wealth Strategies's MED Position: Q1 2023 in Review

Insight Wealth Strategies sold out of Medifast (MED) in Q1 2023, closing a stake of 1,867 shares — an estimated $215K sold.

Insight Wealth Strategies first reported a position in MED in Q2 2021 and held it in 7 quarters. The position peaked at $395K in Q2 2021. 267 funds tracked by Wall St. Rank hold MED as of Q1 2023.

  • Insight Wealth Strategies reported no remaining Medifast position as of Q1 2023 after selling out during the quarter.
  • Insight Wealth Strategies sold 1,867 Medifast shares in Q1 2023, an estimated $215K.
  • Insight Wealth Strategies first reported a position in Medifast in Q2 2021 and held it in 7 quarters.
  • Insight Wealth Strategies's Medifast position peaked at $395K in Q2 2021.
  • 267 funds tracked by Wall St. Rank held Medifast as of Q1 2023.

Based on Insight Wealth Strategies's 13F filing for Q1 2023, filed 6 Apr 2023.